Sinovac Biotech logo

SVA - Sinovac Biotech News Story

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £192.8m
Position in Universe th / 6827

Brazil grants full approval to Pfizer's COVID-19 vaccine

Tue 23rd February, 2021 12:34pm
SAO PAULO, Feb 23 (Reuters) - Brazilian health regulator
Anvisa has granted full approval to a COVID-19 vaccine developed
by Pfizer Inc  PFE.N  and Germany's BioNTech SE  22UAy.F , the
agency said in a Tuesday statement. 
    That makes it the first vaccine against the novel
coronavirus to receive full approval in Brazil, Anvisa said.
Other vaccines developed by AstraZeneca  AZN.L  and China's
Sinovac Biotech Ltd  SVA.O , have only been approved for
emergency use so far. 

 (Reporting by Eduardo Simoes
Writing by Gabriel Stargardter
Editing by Brad Haynes)
 ((Gabriel.Stargardter@thomsonreuters.com; +55 21998116099;
Reuters Messaging:
gabriel.stargardter.thomsonreuters.com@reuters.net))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.